# 2701 Quantification of genomic loss of heterozygosity enables prospective selection of ovarian cancer patients who may derive benefit from the PARP inhibitor rucaparib

> Research article (European Journal of Cancer, 2015) · cited 15× · AI/ML

**Wikidata**: [openalex:W2477362062](https://www.wikidata.org/wiki/openalex:W2477362062)  
**Source**: https://4ort.xyz/entity/2701-quantification-of-genomic-loss-of-heterozygosity-enables-prospective-selection-of-ovarian-cancer-patients-who-may-d